Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($1.22), $0.05 worse than the analyst estimate of ($1.17).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Gloo Holdings, Inc. (GLOO) Reports Q1 Loss of $0.21/sh, Updates Guidance
• AtlasClear Holdings (ATCH) files $100M mixed shelf
• 3 chip stocks to buy after recent SOX pullback: Citi